Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivoWANG LU, L.-J; RANDERATH, K.Molecular pharmacology. 1984, Vol 26, Num 3, pp 594-603, issn 0026-895XArticle

Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulationVENTURELLI, Sascha; BERGER, Alexander; FULDA, Simone et al.Gut. 2011, Vol 60, Num 2, pp 156-165, issn 0017-5749, 10 p.Article

Comparison of the antileukemic activity of 5-aza-2'-deoxycytidine, 1-β-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemiaMOMPARLER, R. L; MOMPARLER, L. F; SAMSON, J et al.Leukemia research. 1984, Vol 8, Num 6, pp 1043-1049, issn 0145-2126Article

Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the γ-δ-β-globin gene complexCHARACHE, S; DOVER, G; SMITH, K et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1983, Vol 80, Num 15, pp 4842-4846, issn 0273-1134Article

Antiproliferative and Antitumor Effects of Azacitidine Against the Human Myelodysplastic Syndrome Cell Line SKM-1KIMURA, Sachie; KURAMOTO, Kazuya; HOMAN, Junko et al.Anticancer research. 2012, Vol 32, Num 3, pp 795-798, issn 0250-7005, 4 p.Article

Influence of 5'-azacitidine on promoting recovery of cell competence for shoot organogenesis in ArabidopsisTOKUJI, Yoshihiko; TAKANO, Shou; TONOMURA, Motoki et al.Plant cell, tissue and organ culture. 2011, Vol 106, Num 2, pp 289-297, issn 0167-6857, 9 p.Article

Carcinogenicity and haemoglobin synthesis induction by cytidine analoguesCARR, B. I; RAHBAR, S; ASMERON, Y et al.British journal of cancer. 1988, Vol 57, Num 4, pp 395-402, issn 0007-0920Article

THE COMPARATIVE EFFECTS OF 5-AZACYTIDINE AND DIHYDRO-5-AZACYTIDINE ON 4S AND 5S NUCLEAR RNAGLAZER RI; HARTMAN KD.1980; MOLEC. PHARMACOL.; USA; DA. 1980; VOL. 17; NO 2; PP. 250-255; BIBL. 25 REF.Article

Treatment of acute myelogenous leukemia with outpatient azacitidineSUDAN, Nimit; ROSSETTI, James M; SHADDUCK, Richard K et al.Cancer. 2006, Vol 107, Num 8, pp 1839-1843, issn 0008-543X, 5 p.Article

THE EFFECT OF 5-AZACYTIDINE AND DIHYDRO-5-AZACYTIDINE ON NUCLEAR RIBOSOMAL RNA AND POLY(A) RNA SYNTHESIS IN L1210 CELLS IN VITROGLAZER RI; PEALE AL; BEISLER JA et al.1980; MOLEC. PHARMACOL.; USA; DA. 1980; VOL. 17; NO 1; PP. 111-117; BIBL. 27 REF.Article

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation settingSANCHEZ-ABARCA, Luis I; GUTIERREZ-COSIO, Silvia; FLORES, Teresa et al.Blood. 2010, Vol 115, Num 1, pp 107-121, issn 0006-4971, 15 p.Article

5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylationZHOU, Guo-Shun; ZHANG, Xiao-Lei; WU, Jun-Ping et al.Cytotechnology (Dordrecht). 2009, Vol 60, Num 1-3, pp 11-22, issn 0920-9069, 12 p.Article

5 -Azacytidine -induced methyltransferase-DNA adducts block DNA replication in vivoKENNY KUO, H; GRIFFITH, Jack D; KREUZER, Kenneth N et al.Cancer research (Baltimore). 2007, Vol 67, Num 17, pp 8248-8254, issn 0008-5472, 7 p.Article

Frequencies of occurence of all human chromosomes in micronuclei from normal and 5-azacytidine-treated lymphocytes as revealed by chromosome paintingFAUTH, E; SCHERTHAN, H; ZANKL, H et al.Mutagenesis. 1998, Vol 13, Num 3, pp 235-241, issn 0267-8357Article

THE COMPARATIVE EFFECTS OF 5-AZACYTIDINE AND DIHYDRO-5-AZACYTIDINE ON POLYSOMAL RNA IN EHRLICH ASCITES CELLS IN VITROHSIN LI LIN; GLAZER RI.1981; MOL. PHARMACOL.; ISSN 0026-895X; USA; DA. 1981; VOL. 20; NO 3; PP. 644-648; BIBL. 30 REF.Article

TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidineMCGREGOR, D. B; BROWN, A. G; CATTANACH, P et al.Carcinogenesis (New York. Print). 1989, Vol 10, Num 11, pp 2003-2008, issn 0143-3334Article

Combination strategies in myelodysplastic syndromesORNSTEIN, Moshe C; SEKERES, Mikkael A.International journal of hematology. 2012, Vol 95, Num 1, pp 26-33, issn 0925-5710, 8 p.Article

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromesLEE, Yun-Gyoo; KIM, Inho; PARK, Yong et al.British journal of haematology. 2013, Vol 161, Num 3, pp 339-347, issn 0007-1048, 9 p.Article

Optimizing hypomethylating agents in myelodysplastic syndromesITZYKSON, Raphael; FENAUX, Pierre.Current opinion in hematology. 2012, Vol 19, Num 2, pp 65-70, issn 1065-6251, 6 p.Article

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseSOCKEL, Katja; WERMKE, Martin; RADKE, Jörgen et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1568-1570, issn 0390-6078, 3 p.Article

Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic SyndromesSILVERMAN, Lewis R; FENAUX, Pierre; MUFTI, Ghulam J et al.Cancer. 2011, Vol 117, Num 12, pp 2697-2702, issn 0008-543X, 6 p.Article

Low-Dose Azacitidine After Allogeneic Stem Cell Transplantation for Acute LeukemiaJABBOUR, Elias; GIRALT, Sergio; KANTARJIAN, Hagop et al.Cancer. 2009, Vol 115, Num 9, pp 1899-1905, issn 0008-543X, 7 p.Article

Decitabine improves patient outcomes in myelodysplastic syndromes : Results of a phase III randomized studyKANTARJIAN, Hagop; ISSA, Jean-Pierre J; HELMER, Richard et al.Cancer. 2006, Vol 106, Num 8, pp 1794-1803, issn 0008-543X, 10 p.Article

Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacyBRECCIA, Massimo; MOLICA, Matteo; ZACHEO, Irene et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 11, pp 1621-1630, issn 1465-6566, 10 p.Article

Eosinophilic Pneumonia Associated With Azacitidine in a Patient With Myelodysplastic SyndromeNAIR, Girish B; CHARLES, Melissa; OGDEN, Lorna et al.Respiratory care. 2012, Vol 57, Num 4, pp 631-633, issn 0020-1324, 3 p.Article